Skip Nav Destination

Issue Archive

Select Year

Issue

INSIDE BLOOD ADVANCES

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?

David Qualls,Caron A. Jacobson

View Articletitled, Comorbidities in DLBCL: too "Severe4" CAR-T therapy?

REVIEW ARTICLES

Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead

Oren Pasvolsky,Partow Kebriaei,Bijal D. Shah,Elias Jabbour,Nitin Jain

View Articletitled, Chimeric antigen receptor T-cell therapy for adult B-cell acute lymphoblastic leukemia: state-of-the-(C)ART and the road ahead

Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP

Julia-Annabell Georgi,Jan Moritz Middeke,Martin Bornhäuser,Axel Matzdorff,Karolin Trautmann-Grill

View Articletitled, Deciphering the genetic basis of immune thrombocytopenia: current evidence for genetic predisposition in adult ITP

CLINICAL TRIALS AND OBSERVATIONS

Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia
Clinical Trials & Observations

Robby Engelmann,Nadja Jaekel,Sabrina Jotschke,Beatrice Ludwig-Kraus,Frank Bernhard Kraus,Neha Kumari,Susann Schulze,Michael Hecker,Christina Zahn,Haifa Kathrin Al-Ali,Christian Junghanss,Sebastian Böttcher

View Articletitled, Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia

Supplemental data

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
Clinical Trials & Observations

View Articletitled, Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Supplemental data

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
Clinical Trials & Observations

View Articletitled, A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma

Supplemental data

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?

David Qualls,Caron A. Jacobson

View Articletitled, Comorbidities in DLBCL: too "Severe4" CAR-T therapy?

Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials
Clinical Trials & Observations

View Articletitled, Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials

Supplemental data

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia
Clinical Trials & Observations

Seth E. Karol,Elaine Coustan-Smith,Stanley Pounds,Lei Wang,Hiroto Inaba,Raul C. Ribeiro,Ching-Hon Pui,Jeffery M. Klco,Jeffrey E. Rubnitz

View Articletitled, Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia

Supplemental data

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
Clinical Trials & Observations

Saad Z. Usmani,Hang Quach,Maria-Victoria Mateos,Ola Landgren,Xavier Leleu,David Siegel,Katja Weisel,Xiaomei Shu,Chuang Li,Meletios Dimopoulos

View Articletitled, Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study

Supplemental data

GENE THERAPY

A comprehensive landscape of transcription profiles and data resources for human leukemia

Mei Luo,Ya-Ru Miao,Ya-Juan Ke,An-Yuan Guo,Qiong Zhang

View Articletitled, A comprehensive landscape of transcription profiles and data resources for human leukemia

Supplemental data

HEALTH SERVICES AND OUTCOMES

Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy

P. Connor Johnson,Tejaswini Dhawale,Richard A. Newcomb,Hermioni L. Amonoo,Mitchell W. Lavoie,Dagny Vaughn,Kyle Karpinski,Areej El-Jawahri

View Articletitled, Longitudinal patient-reported outcomes in patients receiving chimeric antigen receptor T-cell therapy

Supplemental data

Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease

Lana Mucalo,Joshua J. Field,Janelle Highland,Hamda Khan,Jane S. Hankins,Ashima Singh,Amanda M. Brandow

View Articletitled, Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease

Supplemental data

HEMATOPOIESIS AND STEM CELLS

Physioxia improves the selectivity of hematopoietic stem cell expansion cultures

Kyomi J. Igarashi,Iwo Kucinski,Yan Yi Chan,Tze-Kai Tan,Hwei Minn Khoo,David Kealy,Joydeep Bhadury,Ian Hsu,Pui Yan Ho,Kouta Niizuma,John W. Hickey,Garry P. Nolan,Katherine S. Bridge,Agnieszka Czechowicz,Berthold Gottgens,Hiromitsu Nakauchi,Adam C. Wilkinson

View Articletitled, Physioxia improves the selectivity of hematopoietic stem cell expansion cultures

Supplemental data

IMMUNOBIOLOGY AND IMMUNOTHERAPY

Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma

Keisuke Watanabe,Angela M. Gomez,Shunichiro Kuramitsu,Mikko Siurala,Tong Da,Sangya Agarwal,Decheng Song,John Scholler,Antonia Rotolo,Avery D. Posey, Jr.,Alain H. Rook,Paul L. Haun,Marco Ruella,Regina M. Young,Carl H. June

View Articletitled, Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma

Supplemental data

LYMPHOID NEOPLASIA

Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL

Anya L. Levinson,Karensa Tjoa,Benjamin Huang,Lauren K. Meyer,Mi-Ok Kim,Samuel W. Brady,Jinghui Zhang,Kevin Shannon,Anica M. Wandler

View Articletitled, Opposing effects of KDM6A and JDP2 on glucocorticoid sensitivity in T-ALL

Supplemental data

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma
Clinical Trials & Observations

Maciej Tatarczuch,Mark Waltham,Jake Shortt,Galina Polekhina,Eliza A. Hawkes,Shir-Jing Ho,Judith Trotman,Daniella Brasacchio,Melannie Co,Jessica Li,Vanitha Ramakrishnan,Karin Dunne,Stephen S. Opat,Gareth P. Gregory,on behalf of the Australasian Leukaemia and Lymphoma Group

View Articletitled, Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma

Supplemental data

Unraveling the genetics of transformed splenic marginal zone lymphoma

View Articletitled, Unraveling the genetics of transformed splenic marginal zone lymphoma

Supplemental data

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
Clinical Trials & Observations

View Articletitled, Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial

Supplemental data

MYELOID NEOPLASIA

Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
Clinical Trials & Observations

Daniel Tuyet Kristensen,Andreas Kisbye Øvlisen,Lasse Hjort Kyneb Jakobsen,Marianne Tang Severinsen,Louise Hur Hannig,Jørn Starklint,Morten Hagemann Hilsøe,Anders Pommer Vallentin,Mette Brabrand,Hans Carl Hasselbalch,Tarec Christoffer El-Galaly,Anne Stidsholt Roug

View Articletitled, Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study

Supplemental data

The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma

Steven Findlay,Remya Nair,Ronald A. Merrill,Zafir Kaiser,Alexandre Cajelot,Zahra Aryanpour,John Heath,Catherine St-Louis,David Papadopoli,Ivan Topisirovic,Julie St-Pierre,Michael Sebag,Aparna H. Kesarwala,Laura Hulea,Eric B. Taylor,Mala Shanmugam,Alexandre Orthwein

View Articletitled, The mitochondrial pyruvate carrier complex potentiates the efficacy of proteasome inhibitors in multiple myeloma

Supplemental data

Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells

Yu-Tai Chang,Ian Chiu,Qiuju Wang,Jorge Bustamante,Wenxuan Jiang,Kiera Rycaj,Song Yi,Joey Li,Jeanne Kowalski-Muegge,William Matsui

View Articletitled, Loss of p53 enhances the tumor-initiating potential and drug resistance of clonogenic multiple myeloma cells

Supplemental data

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
Clinical Trials & Observations

View Articletitled, Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation

Supplemental data

Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function

Yoshikane Kikushige,Toshihiro Miyamoto,Yu Kochi,Yuichiro Semba,Maki Ohishi,Hidetoshi Irifune,Kiwamu Hatakeyama,Yuya Kunisaki,Takeshi Sugio,Teppei Sakoda,Kohta Miyawaki,Koji Kato,Tomoyoshi Soga,Koichi Akashi

View Articletitled, Human acute leukemia uses branched-chain amino acid catabolism to maintain stemness through regulating PRC2 function

Supplemental data

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
Clinical Trials & Observations

View Articletitled, Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms

Supplemental data

Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS

View Articletitled, Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS

Supplemental data

Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study
Clinical Trials & Observations

Stuart Scott,Richard Dillon,Christian Thiede,Sadia Sadiq,Ashley Cartwright,Hazel J. Clouston,Debbie Travis,Katya Mokretar,Nicola Potter,Andrew Chantry,Liam Whitby

View Articletitled, Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study

Supplemental data

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

View Articletitled, Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Supplemental data

PLATELETS AND THROMBOPOIESIS

Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets

Peter A. A. Norris,Zoya Tawhidi,Ulrich J. Sachs,Christine M. Cserti-Gazdewich,Yulia Lin,Jeannie Callum,Lazaro Gil Gonzalez,Yuexin Shan,Donald R. Branch,Alan H. Lazarus

View Articletitled, Serum from half of patients with immune thrombocytopenia triggers macrophage phagocytosis of platelets

Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia

Joseph Olivera,Vida Zhang,Elizabeta Nemeth,Tomas Ganz

View Articletitled, Erythroferrone exacerbates iron overload and ineffective extramedullary erythropoiesis in a mouse model of β-thalassemia

Supplemental data

EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts

Ji Wu,Kenta Moriwaki,Tatsuya Asuka,Ritsuko Nakai,Satoshi Kanda,Manabu Taniguchi,Tatsuki Sugiyama,Shin-ichiro Yoshimura,Masataka Kunii,Takashi Nagasawa,Naoki Hosen,Eiji Miyoshi,Akihiro Harada

View Articletitled, EHBP1L1, an apicobasal polarity regulator, is critical for nuclear polarization during enucleation of erythroblasts

Supplemental data

TRANSPLANTATION

Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
Clinical Trials & Observations

Emily C. Liang,Simone E. Dekker,Jean M. G. Sabile,Stefan Torelli,Amy Zhang,Katharine Miller,Parveen Shiraz,Brandon Hayes-Lattin,Jessica T. Leonard,Lori Muffly

View Articletitled, Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation

Supplemental data

Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand

View Articletitled, Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand

Supplemental data

PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation

A. Samer Al-Homsi,Frank Cirrone,Stephanie Wo,Kelli Cole,J. Andres Suarez-Londono,Sharon L. Gardner,Jingmei Hsu,Kelsey Stocker,Benedetto Bruno,Judith D. Goldberg,Benjamin A. Levinson,Maher Abdul-Hay

View Articletitled, PTCy, abatacept, and a short course of tacrolimus for GVHD prevention after haploidentical transplantation

Supplemental data

A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study

View Articletitled, A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study

Supplemental data

Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes

Shannon Herzog,Daniel J. Weisdorf,Ryan Shanley,Ahmad Rayes,Shernan G. Holtan,Jo-Anne Young,Margaret L. MacMillan,Najla El Jurdi

View Articletitled, Chronic GVHD after steroid-sensitive, -dependent, and -refractory acute GVHD: incidence and clinical outcomes

Supplemental data

Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

View Articletitled, Alemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT

Supplemental data

RESEARCH LETTERS

Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma

Yuxuan Che,Yang Liu,Yijing Li,Joseph M. McIntosh,Alexa Jordan,Fangfang Yan,Wei Wang,Lei Nie,Heng-Huan Lee,Jingling Jin,Yixin Yao,Zhongming Zhao,Vivian Changying Jiang,Michael Wang

View Articletitled, Dual targeting of CDK4/6 and Bcl-2 exhibits a potent antitumor effect on mantle cell lymphoma

Supplemental data

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
Clinical Trials & Observations

Timothy Schieber,Anthony Li,Jordan Lundberg,Tracy Wiczer,Timothy Voorhees

View Articletitled, Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders

Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma

Elisa Gelli,Debora Soncini,Pamela Becherini,Claudia Martinuzzi,Katia Todoerti,Antonia Cagnetta,Sara Aquino,Fabio Guolo,Maurizio Miglino,Santina Bruzzone,Alessio Nencioni,Antonino Neri,Roberto M. Lemoli,Michele Cea

View Articletitled, Targeting the deacetylase SIRT6 unveils spliceosome deregulation as exploitable vulnerability for aggressive myeloma

Supplemental data

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
Clinical Trials & Observations

View Articletitled, Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma

Supplemental data

Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms

Colleen Isabelle,William T. Johnson,Kathleen McConnell,Ashley Vogel,Jonathan E. Brammer,Amy Boles,Robyn Keller,Paola Sindaco,Liam Nisenfeld,Guldeep Uppal,Neda Nikbakht,Bruno Calabretta,Patrizia Porazzi,Jerald Gong,Nitin Chakravarti,Pierluigi Porcu,Anjali Mishra

View Articletitled, Preclinical evaluation of anti-CD38 therapy in mature T-cell neoplasms

Supplemental data

Correcting the record on anemia of aging: a statistical reanalysis

Geoffrey G. Fell,David G. Nathan,Donna S. Neuberg

View Articletitled, Correcting the record on anemia of aging: a statistical reanalysis

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
Clinical Trials & Observations

Rami S. Komrokji,Luis E. Aguirre,Najla H. Al Ali,Onyee Chan,Zhuoer Xie,Andrew Kuykendall,Kendra Sweet,Jeffrey E. Lancet,Eric Padron,David A. Sallman

View Articletitled, Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Yassine Al Tabaa,Rene Oliver Casasnovas,Clio Baillet,Emmanuel Bachy,Emmanuelle Nicolas-Virelizier,Jean Marc Schiano De colella,Clement Bailly,Salim Kanoun,Stéphanie Guidez,Emmanuel Gyan,Remy Gressin,Nadine Morineau,Loic Ysebaert,Steven Le Gouill,Herve Tilly,Roch Houot,F. Morschhauser,Guillaume Cartron,Charles Herbaux

View Articletitled, Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group

Supplemental data

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
Clinical Trials & Observations

Matko Kalac,Salvia Jain,Constantine S. Tam,Zhengrui Xiao,Francesca Montanari,Jennifer Kanakry,Bryan D. Huber,Mendel Goldfinger,Owen A. O’Connor,Enrica Marchi

View Articletitled, Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma

Supplemental data

COMMENTARIES

BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib

Ross A. Jackson,Robert G. Britton,Sandrine Jayne,Susann Lehmann,Caroline M. Cowley,Christopher S. Trethewey,Victoria M. Smith,Ralf Schmid,Christopher Fegan,Harriet S. Walter,Martin J. S. Dyer

View Articletitled, BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib

Supplemental data

Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease

Catherine R. Hoyt,Andrew M. Heitzer,Steven J. Hardy

View Articletitled, Commentary on the ASH 2020 guidelines on cognitive screening and intervention in sickle cell disease

The value of the old and the new

Paul Monagle,Christoph Male,Leslie Raffini

View Articletitled, The value of the old and the new

ERRATA

Liem RI, Lanzkron S, Coates TD, et al. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv. 2019;3(23):3867-3897.

View Articletitled, Liem RI, Lanzkron S, Coates TD, et al. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease. Blood Adv. 2019;3(23):3867-3897.

Kennedy VE, Wong C, Huang C-Y, et al. Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma. Blood Adv. 2021;5(23):5344-5348.

View Articletitled, Kennedy VE, Wong C, Huang C-Y, et al. Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma. Blood Adv. 2021;5(23):5344-5348.

Cover Image

Cover Image

Immunofluorescence staining of the mitochondrial marker COXIV (green) and 4′,6-diamidino-2-phenylindole (blue) in hindlimb muscles from E18.5 embryos are shown. Deletion of EHBP1L1 causes centronuclear myopathy–like alterations in mouse skeletal muscles, manifested as increased abnormal central positioning of nuclei and mitochondria. See the article by Wu et al.
Front Matter
Editorial Board

Issue Archive

Table of Contents

INSIDE BLOOD ADVANCES

REVIEW ARTICLES

CLINICAL TRIALS AND OBSERVATIONS

Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia Clinical Trials & Observations

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study Clinical Trials & Observations

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma Clinical Trials & Observations

Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials Clinical Trials & Observations

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia Clinical Trials & Observations

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study Clinical Trials & Observations

GENE THERAPY

HEALTH SERVICES AND OUTCOMES

HEMATOPOIESIS AND STEM CELLS

IMMUNOBIOLOGY AND IMMUNOTHERAPY

LYMPHOID NEOPLASIA

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma Clinical Trials & Observations

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial Clinical Trials & Observations

MYELOID NEOPLASIA

Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study Clinical Trials & Observations

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation Clinical Trials & Observations

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms Clinical Trials & Observations

Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study Clinical Trials & Observations

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

TRANSPLANTATION

Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation Clinical Trials & Observations

RESEARCH LETTERS

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders Clinical Trials & Observations

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma Clinical Trials & Observations

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Clinical Trials & Observations

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma Clinical Trials & Observations

COMMENTARIES

ERRATA

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only

Vector-based SARS-CoV-2 vaccination is associated with improved T-cell responses in hematological neoplasia
Clinical Trials & Observations

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study
Clinical Trials & Observations

A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma
Clinical Trials & Observations

Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials
Clinical Trials & Observations

Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemia
Clinical Trials & Observations

Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR study
Clinical Trials & Observations

Molecular associations of response to the new-generation BTK inhibitor zanubrutinib in marginal zone lymphoma
Clinical Trials & Observations

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial
Clinical Trials & Observations

Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study
Clinical Trials & Observations

Impact of type of induction therapy on outcomes in older adults with AML after allogeneic stem cell transplantation
Clinical Trials & Observations

Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
Clinical Trials & Observations

Assessment of acute myeloid leukemia molecular measurable residual disease testing in an interlaboratory study
Clinical Trials & Observations

Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
Clinical Trials & Observations

Successful obinutuzumab administration after rituximab discontinuation due to intolerance in patients with hematologic disorders
Clinical Trials & Observations

Prospective geriatric assessment and geriatric consultation in CAR T-cell therapy for older patients with lymphoma
Clinical Trials & Observations

Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes
Clinical Trials & Observations

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
Clinical Trials & Observations